| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |